*RECRUIT environment is a clinical trial-compliant environment under an IRB (Institutional Review Board)
“Viz RECRUIT permits us to automatically screen patients for clinical trial enrollment, ensuring we can offer cutting-edge studies and treatments to more eligible patients.”
Dr. Chris Kellner
Neurosurgeon, Principal Investigator
Mount Sinai Health System
Viz RECRUIT is proven to speed up clinical trial enrollment by more than 200%. You’re probably thinking, “does that mean I have to double the amount of work to realize that speed?” Nope.
Viz is used by more than 1,200 hospitals across the globe, and we currently offer Viz RECRUIT in three therapy areas — Neuro, Cardiac, and Vascular (with more on the way).
Through AI-powered disease detection and improved operational efficiencies, Viz RECRUIT can make this process faster by identifying eligible patients through the Viz platform.
With real time access to hospital imaging, Viz’ AI-powered technology identifies clinical trial patients at the time of evaluation. That means around the clock discovery with notifications sent to the clinical and research teams.
Have specific criteria for your trial? No problem. Viz uses customized AI-powered disease detection based on your specific inclusion and exclusion criteria so you can pre-screen trial eligible candidates across the health system. You can be certain qualified patients are captured for your clinical trial, increasing the likelihood they are enrollment-eligible.
Why just look for candidates in the hub center when you can expand to include the community and rural spoke centers? Viz’ cloud-based technology broadens the recruitment funnel in both size and diversity by also identifying existing patients in the database that are trial-eligible.
Ensure equity in your clinical trials and leave no stone unturned.
Once a clinical trial candidate is identified, mobile and desktop alerts are sent to the research team to guarantee they are screened for your trial. And those alerts get noticed. 100% of Viz RECRUIT alerts are viewed by research teams, with 50% read within the first ten minutes.
The Viz platform includes HIPAA compliant communication so you can coordinate about eligible patients across your network of research and clinical teams.
Different hospitals, different systems, different teams — doesn’t this get messy? Not with Viz. Viz RECRUIT integrates seamlessly with healthcare IT systems of record (EHR, core labs, etc), creating a complete patient composite to simplify the screening process.
Plus, it’s designed with an expedited screening to enrollment process.
Quickly identifying and evaluating these patients has been a game changer in terms of our enrollment processes for clinical trials.
Quickly identifying and evaluating these patients has been a game changer in terms of our enrollment processes for clinical trials.
By automating a lot of these processes, we’ve been able to streamline data collection and data analysis, which is what clinical trials need.
By automating a lot of these processes, we’ve been able to streamline data collection and data analysis, which is what clinical trials need.
Viz RECRUIT is making the lives of my overworked research team easier by boosting resource capacity and decreasing enrollment timelines for trials, the time savings for not having to manually screen patients is substantial.
Viz RECRUIT is making the lives of my overworked research team easier by boosting resource capacity and decreasing enrollment timelines for trials, the time savings for not having to manually screen patients is substantial.
Viz RECRUIT cuts out 15-minutes several times a week that I spend reviewing imaging with my research coordinator to confirm measurements.
Viz RECRUIT cuts out 15-minutes several times a week that I spend reviewing imaging with my research coordinator to confirm measurements.
The addition of Viz RECRUIT to the APEX-AV team is the perfect marriage of AI blended with new technology with the purpose of improving patient care in pulmonary embolism.
The addition of Viz RECRUIT to the APEX-AV team is the perfect marriage of AI blended with new technology with the purpose of improving patient care in pulmonary embolism.
RECRUIT alerts serve as a needed reminder for my team to follow up on whether the patient is a good candidate for all our trials.
RECRUIT alerts serve as a needed reminder for my team to follow up on whether the patient is a good candidate for all our trials.
Six technology companies provide 6-minute presentations on DCTs and better patient access. During the Viz.ai segment, hear from Principal Investigators on how they efficiently source and enroll patients identified in the medical practice setting using AI.
Jayme Strauss, Chief Clinical Officer at Viz.ai speaks at Mobile Tech in Clinical Trials 2022.
Jayme Strauss, Chief Clinical Officer at Viz.ai speaks at Mobile Tech in Clinical Trials 2022.
Viz.ai is now focused on positioning its joined-up AI software as standardsetter for broader patient engagement with big pharma.
Viz.ai is now focused on positioning its joined-up AI software as standardsetter for broader patient engagement with big pharma.
